Hackman Jeffrey S. 4
4 · FENNEC PHARMACEUTICALS INC. · Filed Aug 19, 2024
Insider Transaction Report
Form 4
Hackman Jeffrey S.
DirectorChief Executive Officer
Transactions
- Award
Stock Options
2024-08-15$5.58/sh+400,000$2,232,000→ 400,000 totalExercise: $5.58From: 2025-08-05Exp: 2034-08-05→ Common Shares (400,000 underlying)
Footnotes (2)
- [F1]On August 15, 2024, Jeffrey Hackman was granted incentive stock options to purchase 400,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan.
- [F2]One-third of the shares subject to this option may be exercised as of August 5, 2025 ("Vesting Commencement Date"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of August 5, 2027, 100% of the total number of shares subject to this option shall be vested.